Xie et al. found that Sox8 expression was positively associated with chemotherapeutic resistance, higher lymph node metastasis, advanced tumor stage, and shorter overall survival in HNSCC patients[110]. This evidence concerns the gene SOX8 and head and neck squamous cell carcinoma.